Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia

Clinical trial NCT03368170 · COMPLETED

Trial details

NCT number: NCT03368170
Sponsor: Integrative Research Laboratories AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2018-04-12
Primary completion: 2019-06-12
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.